$1 million grant to RI Hospital M.D. for primary care melanoma screening training program
Providence, RI Rhode Island Hospital dermatologist Martin Weinstock, MD, PhD, has received a $1 million, 2-year Team Science Award grant from the Melanoma
Research Alliance to serve as principal investigator to develop a training program for primary care physicians to improve melanoma
Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells
An international team of researchers has identified a new method for selectively killing metastatic melanoma
cells, which may lead to new areas for drug development in melanoma
- a cancer that is highly resistant to current treatment strategies.
Richmond, Va. (Vocus) Au...
Researchers identify new method to selectively kill metastatic melanoma cells
RICHMOND, Va. (August 3, 2009) An international team of researchers has identified a new method for selectively killing metastatic melanoma
cells, which may lead to new areas for drug development in melanoma
a cancer that is highly resistant to current treatment strategies.
Researchers from V...
NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
FT. MYERS, Fla., July 24 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer genetics testing services announced today that it has entered into a Strategic Supply Agreement with Abbott (NYSE: ABT ). The Agreement provides for Abbott t...
Moles and melanoma -- researchers find genetic links to skin cancer
New research has shown why people with the greatest number of moles are at increased risk of the most dangerous form of skin cancer.
The study, led by Professors Julia Newton Bishop and Tim Bishop of the Melanoma
Genetics Consortium (GenoMEL) at the University of Leeds, looked at more than 10,00...
New Study Says Purported Melanoma Epidemic is Vastly Overstated
British Journal of Dermatology study blames physician misdiagnosis as the likely cause of apparent uptick in melanoma
WASHINGTON, June 22 /PRNewswire-USNewswire/ -- A newly released study in the June 2009 British Journal of Dermatology that reviews data from a 13-year period in the east...
Avoid the Burn: First Sunscreen to Earn the Melanoma International Foundation Seal of Approval Expands Distribution Throughout Northern California
Specially formulated for sensitive skin and to block UVA and UVB rays, Sierra Summits now available at Raley's stores
RENO, Nev., June 4 /PRNewswire/ -- Sunscreens are not created equal. As dermatology experts continue to emphasize the importance of broad spectrum protection that blocks UVA a...
Experts Optimistic About Melanoma Vaccine
Phase 3 study reports improved survival for those with advanced disease,,
SATURDAY, May 30 (HealthDay News) --A vaccine for advanced melanoma
has shown promise in a new study.
is the most serious type of skin cancer. The five year-survival rates for local and metastatic mel...
Pitt melanoma researchers present novel findings at ASCO
PITTSBURGH, May 30 Researchers from the University of Pittsburgh Cancer Institute (UPCI) have identified eight genes that help predict a melanoma
patient's response to treatment. The new findings are being presented at the 45th annual meeting of the American Society of Clinical Oncology (ASCO), M...
BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
WOBURN, Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that updated survival data from its Phase II study in metastatic melanoma
will be presented at the 2009 American Societ...
Early Detection of Melanoma Plus Regular Skin Exams is Vital For Beating Disease
Dermatologists Offer Advice for Reaching Five-Year Survival Mark
SCHAUMBURG, Ill., May 4 /PRNewswire-USNewswire/ -- On television's popular " Grey's Anatomy ," Dr. Izzie Stevens faces a grim diagnosis: stage IV metastatic melanoma
. As the drama unfolds, viewers get a glimpse at why pati...
Top Celebs Tee it for Melanoma at 6th annual Hack n' Smack (Top 10 in Southland Golf Mag)
TARZANA, Calif., April 21 /PRNewswire/ -- Joe Pesci (Goodfellas) , Dennis Haysbert (The Unit), Joe Mantegna (Criminal Minds) , J.K. Simmons (The Closer/Juno) , Kenny Lofton (MLB - Indians) and Ron Perlman (Sons of Anarchy/Hellboy) , will be teeing it up on Monday, May 11th f...
Genes Hike Melanoma Risk Even in Those Who Tan Well
Study finds chances of getting deadly skin cancer higher despite darker coloring
TUESDAY, April 21 (HealthDay News) -- If you have dark eyes, dark hair and tan easily, you might think you don't have to worry much about melanoma.
But new research shows that variations of a particular...
NYU study finds new risk factor for melanoma in younger women
NEW YORK, March 24, 2009 Researchers may have found a more potent risk factor for melanoma
than blistering sunburns, freckling, or family history of the deadly skin disease. In a new study, scientists at NYU Langone Medical Center report that a genetic variation leads to a nearly four-fold increa...
Dr. James F. Pingpank to Present at the Sixth International Symposium on Melanoma and Other Cutaneous Malignancies on March 13- 14, 2009 in New York City
NEW YORK, March 12 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ) , a medical technology company testing its proprietary Percutaneous Hepatic Perfusion ("PHP(TM)") System for the treatment of cancers of the liver, announced today that Dr. James F. Pingpank will present at The...
Drug Could Make Melanoma More Vulnerable to Chemo
Compound disabled protein fueling tumor growth, making therapy more effective
FRIDAY, March 6 (HealthDay News) -- A compound that targets and disables a protein found in melanoma
tumors may make the deadly skin cancer more vulnerable to chemotherapy, early results of a pilot study show...
Drugs From Vegetables May Target Melanoma Tumors
Extracts of broccoli, cabbage block protein in disease spread, study says
THURSDAY, March 5 (HealthDay News) -- A drug based on compounds extracted from cruciferous vegetables such as broccoli and cabbage could offer a potent and safe treatment against melanoma, Penn State College of M...
Non-Profit Gives $800,000 for Melanoma Research in 2009
-Melanoma Research Foundation awards grants to five melanoma
HILLSBOROUGH, N.J., Feb. 24 /PRNewswire-USNewswire/ -- Today the Melanoma
Research Foundation (MRF), the largest independent, national organization devoted to melanoma
in the U.S., announced the recipients of five new r...
Stress May Speed Melanoma Progression
But certain heart drugs may help counter the effect, researchers say
THURSDAY, Feb. 19 (HealthDay News) -- Stress appears to hasten the progression of aggressive or advanced melanoma
skin cancer, but commonly prescribed blood pressure drugs may slow the disease and improve the quality ...
Family History of Melanoma Doubles Parkinson's Risk
Linkage between the two might be genetic, researchers say
MONDAY, Feb. 16 (HealthDay News) -- People with a family history of melanoma
are twice as likely to develop Parkinson's disease, a new study finds.
While the reasons for this association are not clear, other studies have show...
Family history of melanoma linked to Parkinson's disease
SEATTLE People with a family history of melanoma
may have a greater risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009.
The study involved nearly 157,...
Childhood Beach Vacations May Boost Melanoma Risk
Each seaside stay increased skin moles by 5%, study found
TUESDAY, Feb. 3 (HealthDay News) -- Vacations at the shore during childhood may boost the risk of the deadly skin cancer melanoma
later in life, a new study suggests.
Researchers from Denver evaluated 681 children born in 199...
A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe
Ipilimumab Will Earn Decision Resources' Clinical Gold Standard for Stage IV Malignant Melanoma
in 2012, According to a New Report from Decision Resources
WALTHAM, Mass., Jan. 19 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical an...
Educational Symposium to Present Panel Discussion on Melanoma Treatments and Immunotherapy
CONCORD, Mass., Nov. 3 /PRNewswire-USNewswire/ -- The Melanoma
Foundation of New England invites melanoma
patients, survivors, families,
and friends to its fall symposium: "Updates in Melanoma
presented by F. Stephen Hodi, MD, Director of the Melanoma
Program at Dana
Farber Cancer I...
Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late
Specialists Will Give Accredited Course for
Non-Dermatologists about Detection and Management of Melanoma
To be held November 1, 2008 at the Royal Sonesta Hotel Boston,
CONCORD, Mass., Oct. 9 /PRNewswire-USNewswire/ -- The Melanoma
Foundation of New England a...
Prototype test for predicting clinical outcome for melanoma patients
Investigators from the Melbourne Center of the international Ludwig Institute for Cancer Research (LICR) and Pacific Edge Biotchnology Ltd today reported that they have developed a test to predict whether a patient will progress rapidly from Stage III melanoma
to metastatic Stage IV cancer and dea...
Rheumatoid Arthritis Drug Boosts Melanoma Incidence
Patients treated with methotrexate had a threefold increased risk of disease, report says
FRIDAY, June 20 (HealthDay News) -- Rheumatoid arthritis (RA) patients treated with methotrexate have an increased incidence of melanoma
and other cancers, an Australian study says.
Patient's own infection-fighting T cells put late-stage melanoma into long-term remission
SEATTLE Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission. A team led by Cassian Yee, M.D., an associate member of the Clinical Research Division at Fred Hutchinso...
Inherited melanoma risk: What you do know does help you
Salt Lake CityWhen people know the results of genetic tests confirming they have inherited an increased risk of developing melanoma, they follow skin cancer screening recommendations more proactivelymuch like those who have already been diagnosed with the potentially deadly disease, according to r...
Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexate
A chronic, inflammatory disease of unknown origin, rheumatoid arthritis (RA) affects about 1 percent of adults worldwide. Marked by joint destruction, RA often leads to disability and diminished quality of life. It can also lead to an early death from cancer. Various studies have linked RA to a...
Combo Therapy Knocks Out Melanoma Tumors
Chemo was more effective after a protein in growths was inhibited, researchers say
SUNDAY, June 1 (HealthDay News) -- Chemotherapy may be more effective on melanoma
tumors if a protein frequently found in the growth can first be disabled, a new study reports.
Researchers at the Duk...
New combination therapy safe, promising for melanoma patients
CHICAGO, June 1 The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Researchers close in on new melanoma gene
Phoenix, Arizona and Queensland, Australia It has long been known that prolonged exposure to the suns harmful UV rays can lead to Melanoma, the deadliest form of skin cancer. An unanswered question, however, is why some people are more likely to develop melanoma
than others. Despite years of rese...
Scientists identify interacting proteins key to melanoma development, treatment
Researchers have discovered how a mole develops into melanoma
by showing the interaction of two key proteins involved in 60-70 percent of tumors. The Penn State scientists also demonstrate that therapeutic targeting of these proteins is necessary for drugs to effectively treat this deadly form of...
Survival rates appear lower for scalp and neck melanoma than for other sites
Individuals with melanoma
on their scalp or neck appear less likely to survive for five or 10 years than those with melanoma
at other sites, according to a report in the April issue of Archives of Dermatology, one of the JAMA/Archives journals.
rates continue to increase while rates fo...
Gleevec Pushes Advanced Melanoma Into Remission
Woman's case first showing the cancer may have an Achilles' heel, report suggests
THURSDAY, April 17 (HealthDay News) -- The cancer drug Gleevec has forced metastatic melanoma
into remission for the first time, report researchers at the Dana-Farber Cancer Institute in Boston.
Interleukin-12 indicates survival prospects for melanoma patients
SAN DIEGO - Higher blood levels of an immune system protein predict poor survival prospects for melanoma
patients with advanced disease, researchers at The University of Texas M. D. Anderson Cancer Center report today at the annual meeting of the American Association for Cancer Research.
Indoor Tanning Association Launches Campaign Attacking Melanoma Hype
Experts Rethink Sun Exposure in Light of New Evidence Showing the
Benefits of UV Light Outweigh Perceived Risks
WASHINGTON, March 26 /PRNewswire-USNewswire/ -- Today, the Indoor
Tanning Association (ITA) launched an aggressive nationwide campaign
encouraging the public to rethink sun-tan...
DermTech Adds Allan C. Halpern, MD, Chief of Dermatology at Memorial Sloan- Kettering Cancer Center, to Company's Melanoma Advisory Board
LA JOLLA, Calif., March 5 /PRNewswire/ -- DermTech, a biotechnology
company developing molecular diagnostics for the early detection of
melanoma and other diseases, today announced that Allan C. Halpern, MD, has
joined DermTech's Melanoma
Advisory Board. Dr. Halpern is Chief of
Dermatology at ...
HSP90: New point of view on melanoma of the eye, at the MUHC
Montreal, 19 February, 2008 - Ocular melanoma
is rarely detected before it has grown large enough to impair vision or to metastasize. This makes it a particularly challenging disease to fight, especially since chemotherapy is not very effective.
Now, the PhD research project led by Dr. Dana Fain...